0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 1,555,359 1,555,359 1,555,359 xbrli:pure xbrli:shares iso4217:GBP 07484749 2024-04-01 2025-03-31 07484749 2025-03-31 07484749 2024-03-31 07484749 2023-04-01 2024-03-31 07484749 2024-03-31 07484749 2023-03-31 07484749 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07484749 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 07484749 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 07484749 bus:Director1 2024-04-01 2025-03-31 07484749 core:WithinOneYear 2025-03-31 07484749 core:WithinOneYear 2024-03-31 07484749 core:AfterOneYear 2025-03-31 07484749 core:ShareCapital 2025-03-31 07484749 core:ShareCapital 2024-03-31 07484749 core:RetainedEarningsAccumulatedLosses 2025-03-31 07484749 core:RetainedEarningsAccumulatedLosses 2024-03-31 07484749 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 07484749 core:Non-currentFinancialInstruments 2025-03-31 07484749 core:Non-currentFinancialInstruments 2024-03-31 07484749 bus:SmallEntities 2024-04-01 2025-03-31 07484749 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07484749 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07484749 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07484749 bus:FullAccounts 2024-04-01 2025-03-31 07484749 bus:OrdinaryShareClass1 2025-03-31 07484749 bus:OrdinaryShareClass1 2024-03-31 07484749 bus:OrdinaryShareClass2 2025-03-31 07484749 bus:OrdinaryShareClass2 2024-03-31 07484749 bus:OrdinaryShareClass3 2025-03-31 07484749 bus:OrdinaryShareClass3 2024-03-31 07484749 bus:AllOrdinaryShares 2025-03-31 07484749 bus:AllOrdinaryShares 2024-03-31 07484749 core:AfterOneYear 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 07484749
Curewell Limited
Filleted Unaudited Financial Statements
31 March 2025
Curewell Limited
Balance Sheet
31 March 2025
2025
2024
Note
£
£
Fixed assets
Investments
4
1,555,359
1,555,359
Current assets
Debtors
5
72,380
750
Cash at bank and in hand
68,453
97,967
---------
--------
140,833
98,717
Creditors: amounts falling due within one year
6
91,026
3,085
---------
--------
Net current assets
49,807
95,632
------------
------------
Total assets less current liabilities
1,605,166
1,650,991
Creditors: amounts falling due after more than one year
7
1,107,765
------------
------------
Net assets
497,401
1,650,991
------------
------------
Capital and reserves
Called up share capital
8
500
1,000
Profit and loss account
496,901
1,649,991
---------
------------
Shareholders funds
497,401
1,650,991
---------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Curewell Limited
Balance Sheet (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 15 October 2025 , and are signed on behalf of the board by:
Mr R M Shah
Director
Company registration number: 07484749
Curewell Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 11 East Barnet Road, New Barnet, Hertfordshire, EN4 8RR.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
4. Investments
Shares in group undertakings
£
Cost
At 1 April 2024 and 31 March 2025
1,555,359
------------
Impairment
At 1 April 2024 and 31 March 2025
------------
Carrying amount
At 31 March 2025
1,555,359
------------
At 31 March 2024
1,555,359
------------
The directors are of the opinion that the carrying value of the company's investments at the reporting date are the same as the market value.
The company owns more than 20% of the issued share capital of the company listed below.
Proportion
Subsidiary undertakings Holding Held Nature of
business
Mountford Chemists Limited Ordinary 100% Retail
pharmacy
shares
5. Debtors
2025
2024
£
£
Amounts owed by group undertakings
72,380
750
--------
----
6. Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
83,333
Corporation tax
4,693
1,585
Other creditors
3,000
1,500
--------
-------
91,026
3,085
--------
-------
7. Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
1,107,765
------------
----
The bank loan is secured by fixed and floating charges over the properties held in the subsidiary.
8. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
A Ordinary shares of £ 0.50 each
250
125
250
125
B Ordinary shares of £ 0.50 each
375
188
375
188
C Ordinary shares of £ 0.50 each
375
188
375
188
-------
----
-------
----
1,000
500
1,000
500
-------
----
-------
----
9. Related party transactions
The company has taken advantage of the exemption from disclosing related party transactions with other companies that are wholly owned within the group.
10. Controlling party
There is no controlling party as no shareholder has more than 50% beneficial holding in the company.